Your browser doesn't support javascript.
loading
Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers.
Kriege, Mieke; Jager, Agnes; Hollestelle, Antoinette; Berns, Els M J J; Blom, Jannet; Meijer-van Gelder, Marion E; Sieuwerts, Anieta M; van den Ouweland, Ans; Collée, J Margriet; Kroep, Judith R; Martens, John W M; Hooning, Maartje J; Seynaeve, Caroline.
Affiliation
  • Kriege M; Department of Medical Oncology, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands, a.kriege@erasmusmc.nl.
J Cancer Res Clin Oncol ; 141(10): 1879-87, 2015 Oct.
Article in En | MEDLINE | ID: mdl-25958056
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Anthracyclines / Taxoids / Checkpoint Kinase 2 / Mutation Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Cancer Res Clin Oncol Year: 2015 Document type: Article Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Anthracyclines / Taxoids / Checkpoint Kinase 2 / Mutation Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: J Cancer Res Clin Oncol Year: 2015 Document type: Article Country of publication: Germany